Ankerias helps clinicians working with chronic and neuropathic pain better understand neuropathic pain mechanisms and support diagnosis.
Built on real-world health data and AI-assisted insights, our platform supports clinical decision-making across the care pathway from diagnosis to treatment, including identifying patients who may benefit from spinal cord stimulation (SCS), intraoperative support, and treatment optimization.
Ankerias helps clinicians working with chronic and neuropathic pain better understand pain mechanisms and support diagnosis.
Built on real-world health data and AI-assisted insights, our platform supports clinical decision-making across the care pathway from diagnosis to treatment, including identifying patients who may benefit from spinal cord stimulation (SCS), intraoperative support, and treatment optimization.
From diagnosis to personalized treatment in neuropathic pain
From diagnosis to personalized treatment in neuropathic pain
Global neuropathic pain
Everyone deserves to live a healthy and pain-free life. Around 1.5 billion individuals globally suffer from chronic pain, with neuropathic pain affecting 7–10% of these cases. Too many are left without adequate care, leading to ongoing suffering, as neuropathic pain is often underdiagnosed in clinical practice.
Clinical gap in neuropathic pain
Neuropathic pain is difficult to recognize and diagnose, and many patients do not receive appropriate treatment in time.
Effective therapies such as spinal cord stimulation (SCS) exist, yet the vast majority of eligible patients remain untreated. Up to 95% of patients who could benefit from SCS do not receive it, often due to delays in diagnosis, unclear patient selection, and fragmented care pathways.
Ankerias’s solution
Ankerias provides a digital platform for supporting diagnosis and treatment decisions in neuropathic pain.
The platform integrates patient-reported data, physiological signals, and longitudinal monitoring to help clinicians identify pain mechanisms and assess patients more effectively.
By combining real-world health data with AI-assisted analysis, Ankerias enables more informed clinical decisions across the care pathway, supporting both early diagnosis and personalized treatment strategies.
Clinical impact
Improving outcomes in neuropathic pain care requires earlier diagnosis and better-informed treatment decisions.
Ankerias supports clinicians across the full care pathway, from diagnosis to treatment selection and optimization, including comprehensive support for spinal cord stimulation (SCS), from identifying suitable patients to intraoperative guidance and long-term therapy optimization.
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients are referred too late, often after long and ineffective treatment pathways. Earlier recognition of neuropathic pain and better patient selection are essential to achieving optimal outcomes.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients are referred too late, often after long and ineffective treatment pathways. Earlier recognition of neuropathic pain and better patient selection are essential to achieving optimal outcomes.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
After years of trying treatments that didn’t work, I was finally offered spinal cord stimulation and it changed everything. I just wish the right care had come earlier.
— Spinal cord stimulation patient, Oulu, Finland
Our mission is to enable earlier diagnosis and more effective treatment of neuropathic pain, including timely access to therapies such as spinal cord stimulation. By combining AI with clinical insight, we support healthcare professionals in making more timely and targeted decisions.
— Hanna Viisanen-Kuopila, CEO & Co-Founder, Ankerias
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients are referred too late, often after long and ineffective treatment pathways. Earlier recognition of neuropathic pain and better patient selection are essential to achieving optimal outcomes.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients are referred too late, often after long and ineffective treatment pathways. Earlier recognition of neuropathic pain and better patient selection are essential to achieving optimal outcomes.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
After years of trying treatments that didn’t work, I was finally offered spinal cord stimulation and it changed everything. I just wish the right care had come earlier.
— Spinal cord stimulation patient, Oulu, Finland
Our mission is to enable earlier diagnosis and more effective treatment of neuropathic pain, including timely access to therapies such as spinal cord stimulation. By combining AI with clinical insight, we support healthcare professionals in making more timely and targeted decisions.
— Hanna Viisanen-Kuopila, CEO & Co-Founder, Ankerias
Meet Team Ankerias
Meet Team Ankerias
We have a very strong background in neuroscience, pain research, data analysis, and AI/ML applications.
Hanna Viisanen-Kuopila
Founder, CEO
PhD, Adj. Prof. in Physiology
Mette Nissen
Medical advisor
MD PhD, Consultant in Neurosurgery,
Kuopio University Hospital
Riku Tikkanen
Co-founder, CTO
MSc in Computer Science
Nitin Williams
AI/ML advisor
PhD, Adj. Prof. in Neuroinformatics University of Helsinki, Visiting researcher Aalto University
Mikko Pitkänen
CFO
Master in Social Sciences
Tapio Jakobsson
Regulatory affairs and quality advisor
MSc in Technology
Pekka Männistö
Health economics advisor
MSc
Alexander Helmut Jung
AI/ML advisor
Associate Professor for ML,
Aalto University
Collaborators
Collaborators
Ankerias News
Follow Ankerias and track the progress of our project.
In 2025, we advanced clinical validation through surveys and early pilots while developing our AI-based platform for neuropathic pain and spinal cord stimulation (SCS).
In 2026, our pre-seed round is ongoing with initial investors committed. We are deepening collaboration with research partners and preparing clinical pilots starting in Q2 2026.
Our focus is to advance validation, expand pilots, and begin initial commercial activities with non-clinical products.
We are continuing discussions with investors as we build toward our next funding round.
Drop us a message and let’s talk.
Ankerias News
Follow Ankerias and track the progress of our project.
In 2025, we advanced clinical validation through surveys and early pilots while developing our AI-based platform for neuropathic pain and spinal cord stimulation (SCS).
In 2026, our pre-seed round is ongoing with initial investors committed. We are deepening collaboration with research partners and preparing clinical pilots starting in Q2 2026.
Our focus is to advance validation, expand pilots, and begin initial commercial activities with non-clinical products.
We are continuing discussions with investors as we build toward our next funding round.
Drop us a message and let’s talk.
We are looking for investors and partners!
Interested to hear more? Contact us.
Ankerias is based in Helsinki, Finland.
Let’s organize a meeting so we can look at Ankerias’s solution in detail, face to face or online.
We should discuss how we could collaborate with you and your organization!
Interested to hear more? Contact us.
Ankerias is based in Helsinki, Finland.
Let’s organize a meeting so we can look at Ankerias’s solution in detail, face to face or online.
We should discuss how we could collaborate with you and your organization!